AmCyte Company
AmCyte develops encapsulated proliferated human islets for transplantation into patients with diabetes. The company specializes in adult stem cell research to treat diabetes with islet replacement therapy.
Founded Date:
1991-01-01
Headquarters:
United States
Technology:
Regenerative Medicine
Industry:
Transplants
Funding Status:
M&A
Investor Type:
Company